Diversity-promoting Institutions Drug Abuse Research Program (DIDARP) (R24)
The summary for the Diversity-promoting Institutions Drug Abuse Research Program (DIDARP) (R24) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Diversity-promoting Institutions Drug Abuse Research Program (DIDARP) (R24): Purpose. This FOA issued by the National Institute on Drug Abuse (NIDA), National Institutes of Health, encourages Resource-Related Research Project Grant (R24) applications from institutions that serve economically disadvantaged students andcommunities.Applications should propose to develop or strengthen the drug abuse research infrastructure at the institution and foster the research career development of a diverse cadre of faculty, students and staff who are currently underrepresented in drug abuse research. Mechanism of Support. This FOA will utilize the Resource-Related Research Projects (R24) grant mechanism. Funds Available and Anticipated Number of Awards. For this funding opportunity, budgets up to $350,000 in directcosts per year and time periods up to 5 years may be requested.Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards supported will depend upon the mechanism number, quality, duration, and cost of the applications received. Budget and Project Period.Budgets for direct costs of up to $350,000 per year and project duration of up to 5 years may be requested.
| Federal Grant Title: | Diversity-promoting Institutions Drug Abuse Research Program (DIDARP) (R24) |
| Federal Agency Name: | National Institutes of Health |
| Grant Categories: | Education Health |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | PAR-11-060 |
| Type of Funding: | Grant |
| CFDA Numbers: | 93.279 |
| CFDA Descriptions: | Drug Abuse and Addiction Research Programs |
| Current Application Deadline: | Sep 09, 2013 |
| Original Application Deadline: | Sep 09, 2013 |
| Posted Date: | Dec 06, 2010 |
| Creation Date: | Dec 06, 2010 |
| Archive Date: | Oct 10, 2013 |
| Total Program Funding: | |
| Maximum Federal Grant Award: | $350,000 |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | |
| Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Public and State controlled institutions of higher education - Private institutions of higher education - Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) .
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]] - Similar Government Grants
- • Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Interven...
- • Neural Ensembles & Used Substances (NExUS) Collaboratory: Building a Multimodal Inventory ...
- • Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Tr...
- • Limited Competition: Growing Great Ideas: Research Education Course in Entrepreneurship an...
- • Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional)
- • NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards
- • Drug Abuse Aspects of Hiv/Aids and Other Infections
- • Epidemiology of Drug Abuse
- More Grants from the National Institutes of Health
- • Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinic...
- • Immune Tolerance Network (UM1 Clinical Trial Required)
- • Coordinating Center for National Resource Network for the Study of Human Auditory and Vest...
- • National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Cl...
- • Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Interven...
